204 related articles for article (PubMed ID: 2553394)
1. Isolation of similar rolipram-inhibitable cyclic-AMP-specific phosphodiesterases from rat brain and heart.
Némoz G; Moueqqit M; Prigent AF; Pacheco H
Eur J Biochem; 1989 Oct; 184(3):511-20. PubMed ID: 2553394
[TBL] [Abstract][Full Text] [Related]
2. Purification of cAMP-specific phosphodiesterase from rat heart by affinity chromatography on immobilized rolipram.
Fougier S; Némoz G; Prigent AF; Marivet M; Bourguignon JJ; Wermuth C; Pacheco H
Biochem Biophys Res Commun; 1986 Jul; 138(1):205-14. PubMed ID: 3017316
[TBL] [Abstract][Full Text] [Related]
3. Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors.
Kelly JJ; Barnes PJ; Giembycz MA
Br J Pharmacol; 1998 May; 124(1):129-40. PubMed ID: 9630352
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of rolipram on partially purified phosphodiesterase 4 from rat brains.
Ohsawa F; Yamauchi M; Nagaso H; Murakami S; Baba J; Sawa A
Jpn J Pharmacol; 1998 Jun; 77(2):147-54. PubMed ID: 9681571
[TBL] [Abstract][Full Text] [Related]
5. Cyclic nucleotide phosphodiesterase in rat neostriatum: multiple isoelectric forms with similar kinetic properties.
Minneman KP
J Neurochem; 1976 Nov; 27(5):1181-9. PubMed ID: 12170605
[TBL] [Abstract][Full Text] [Related]
6. Isolation, biochemical characterization and N-terminal sequence of rolipram-sensitive cAMP phosphodiesterase from human mononuclear leukocytes.
Truong VH; Müller T
FEBS Lett; 1994 Oct; 353(1):113-8. PubMed ID: 7926011
[TBL] [Abstract][Full Text] [Related]
7. Purification, characterization and analysis of rolipram inhibition of a human type-IVA cyclic AMP-specific phosphodiesterase expressed in yeast.
Wilson M; Sullivan M; Brown N; Houslay MD
Biochem J; 1994 Dec; 304 ( Pt 2)(Pt 2):407-15. PubMed ID: 7528009
[TBL] [Abstract][Full Text] [Related]
8. Cyclic nucleotide phosphodiesterases from frog atrial fibers: isolation and drug sensitivities.
Lugnier C; Gauthier C; Le Bec A; Soustre H
Am J Physiol; 1992 Mar; 262(3 Pt 2):H654-60. PubMed ID: 1373036
[TBL] [Abstract][Full Text] [Related]
9. Purification and characterization of a low-Km 3':5'-cyclic adenosine phosphodiesterase from post-meiotic male mouse germ cells.
Giorgi M; Piscitelli D; Rossi P; Geremia R
Biochim Biophys Acta; 1992 May; 1121(1-2):178-82. PubMed ID: 1318079
[TBL] [Abstract][Full Text] [Related]
10. Characterization of cyclic AMP phosphodiesterase isozymes in rat parotid gland.
Imai A; Nashida T; Shimomura H
Arch Oral Biol; 1995 Feb; 40(2):165-8. PubMed ID: 7794130
[TBL] [Abstract][Full Text] [Related]
11. Engineered deletion of the unique N-terminal domain of the cyclic AMP-specific phosphodiesterase RD1 prevents plasma membrane association and the attainment of enhanced thermostability without altering its sensitivity to inhibition by rolipram.
Shakur Y; Pryde JG; Houslay MD
Biochem J; 1993 Jun; 292 ( Pt 3)(Pt 3):677-86. PubMed ID: 7686364
[TBL] [Abstract][Full Text] [Related]
12. Concanavalin A stimulates the Rolipram-sensitive isoforms of cyclic nucleotide phosphodiesterase in rat thymic lymphocytes.
Valette L; Prigent AF; Némoz G; Anker G; Macovschi O; Lagarde M
Biochem Biophys Res Commun; 1990 Jun; 169(3):864-72. PubMed ID: 2163636
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of one of the cyclic AMP phosphodiesterases from rat brain by the neurotropic compound rolipram.
Nemoz G; Prigent AF; Moueqqit M; Fougier S; Macovschi O; Pacheco H
Biochem Pharmacol; 1985 Aug; 34(16):2997-3000. PubMed ID: 2992527
[No Abstract] [Full Text] [Related]
14. Stereospecificity of rolipram actions on eosinophil cyclic AMP-specific phosphodiesterase.
Souness JE; Scott LC
Biochem J; 1993 Apr; 291 ( Pt 2)(Pt 2):389-95. PubMed ID: 8387267
[TBL] [Abstract][Full Text] [Related]
15. The human cyclic AMP-specific phosphodiesterase PDE-46 (HSPDE4A4B) expressed in transfected COS7 cells occurs as both particulate and cytosolic species that exhibit distinct kinetics of inhibition by the antidepressant rolipram.
Huston E; Pooley L; Julien P; Scotland G; McPhee I; Sullivan M; Bolger G; Houslay MD
J Biol Chem; 1996 Dec; 271(49):31334-44. PubMed ID: 8940140
[TBL] [Abstract][Full Text] [Related]
16. Bemoradan--a novel inhibitor of the rolipram-insensitive cyclic AMP phosphodiesterase from canine heart tissue.
Moore JB; Combs DW; Tobia AJ
Biochem Pharmacol; 1991 Jul; 42(3):679-83. PubMed ID: 1650219
[TBL] [Abstract][Full Text] [Related]
17. Relaxation of guinea-pig trachea by cyclic AMP phosphodiesterase inhibitors and their enhancement by sodium nitroprusside.
Turner NC; Lamb J; Worby A; Murray KJ
Br J Pharmacol; 1994 Apr; 111(4):1047-52. PubMed ID: 8032589
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning and transient expression in COS7 cells of a novel human PDE4B cAMP-specific phosphodiesterase, HSPDE4B3.
Huston E; Lumb S; Russell A; Catterall C; Ross AH; Steele MR; Bolger GB; Perry MJ; Owens RJ; Houslay MD
Biochem J; 1997 Dec; 328 ( Pt 2)(Pt 2):549-58. PubMed ID: 9371714
[TBL] [Abstract][Full Text] [Related]
19. Purification and kinetic properties of two soluble forms of calmodulin-dependent cyclic nucleotide phosphodiesterase from rat pancreas.
Vandermeers A; Vandermeers-Piret MC; Rathe J; Christophe J
Biochem J; 1983 May; 211(2):341-7. PubMed ID: 6307278
[TBL] [Abstract][Full Text] [Related]
20. Purification, characterization and production of rabbit antibodies to rat liver particulate, high-affinity, cyclic AMP phosphodiesterase.
Whitson RH; Appleman MM
Biochim Biophys Acta; 1982 Feb; 714(2):279-91. PubMed ID: 6275911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]